Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic Is Not a Responsible Act

被引：0

作者：

Schreiber, Stefan ^{[1
,2
]}

Dignass, Axel ^{[3
]}

Rogge, Annette ^{[4
]}

Rubin, David T. ^{[5
,6
]}

机构：

[1] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Kiel, Germany

[2] Univ Kiel, Excellence Cluster Precis Med Inflammat, Kiel, Germany

[3] Agaples Markus Hosp, Dept Med 1, Frankfurt, Germany

[4] Univ Hosp Schleswig Holstein, Inst Expt Med, Med Eth, Kiel, Germany

[5] Univ Chicago, Inflammatory Bowel Dis Ctr, Chicago, IL 60637 USA

[6] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA

来源：

JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷 / 12期

关键词：

Crohn disease; ulcerative colitis; drug development; registration trial; ethics; regulatory trials;

D O I：

10.1093/ecco-jcc/jjaa127

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The intense competition for resources to combat COVID-19 has greatly reduced access to health care for patients with other diseases. After the disastrous overrun of hospitals through COVID-19 patients in some jurisdictions, availability of resources for 'elective' medical procedures, including care for the chronically ill, has been greatly reduced in many places as a pre-emptive measure before or during the blooming of infection clusters. Pharmaceutical companies have either stopped recruitment or even cancelled ongoing clinical trials in chronic diseases. Pre-emptive triage and its impact on medical ethics is discussed in the framework of care for inflammatory bowel disease.

引用

页码：1765 / 1768

页数：4

共 50 条

[21] Conducting clinical trials during the COVID-19 pandemic
Collier, Erin K.
Hsiao, Jennifer L.
Shi, Vivian Y.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (04) : 330 - 332
[22] Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic
Eltabbakh, Mohamed Mahmoud
Shamkh, Mostafa Abd Alfatah
Bassuny, Ahmed Nagah
Abd Alaty, Waleed Hamed
Sakr, Mohamed Amin
Sherief, Ahmed Fouad
INFLAMMATORY BOWEL DISEASES, 2020, 26 (11) : 1771 - 1778
[23] Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic
Garrido, Isabel
Lopes, Susana
Macedo, Guilherme
INFLAMMATORY BOWEL DISEASES, 2020, 26 (10) : E114 - E115
[24] EFFECTS OF DELAYED ENDOSCOPIES IN INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC
Young, Karen
Hargunani, Devesh
Poylin, Vitaliy
INFLAMMATORY BOWEL DISEASES, 2022, 28 : S82 - S82
[25] Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
Bernstein, Charles N.
Ng, Siew C.
Banerjee, Rupa
Steinwurz, Flavio
Shen, Bo
Carbonnel, Franck
Hamid, Saeed
Sood, Ajit
Yamamoto-Furusho, Jesus K.
Griffiths, Anne
Benchimol, Eric, I
Travis, Simon
Lopes, Susana
Rubin, David T.
Kaplan, Gilaad G.
Armstrong, David
Gearry, Richard
INFLAMMATORY BOWEL DISEASES, 2021, 27 (06) : 836 - 847
[26] ACUITY OF PEDIATRIC INFLAMMATORY BOWEL DISEASE ADMISSIONS PRE AND DURING THE COVID-19 PANDEMIC
Waschmann, Malika
Stuart, Ariana
Lin, Henry
Hunter, Anna
GASTROENTEROLOGY, 2022, 162 (03) : S31 - S31
[27] Review Article: Vaccination for patients with inflammatory bowel disease during the COVID-19 pandemic
Doherty, Jayne
Fennessy, Sean
Stack, Roisin
O' Morain, Neil
Cullen, Garret
Ryan, Elizabeth J.
De Gascun, Cillian
Doherty, Glen A.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (09) : 1110 - 1123
[28] ACUITY OF PEDIATRIC INFLAMMATORY BOWEL DISEASE ADMISSIONS PRE AND DURING THE COVID-19 PANDEMIC
Waschmann, Malika
Stuart, Ariana
Lin, Henry
Hunter, Anna
INFLAMMATORY BOWEL DISEASES, 2022, 28 : S31 - S31
[29] Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply
Deputy, Mohammed
Hart, Ailsa
Faiz, Omar
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1064 - 1064
[30] EFFECTS OF DELAYED ENDOSCOPIES IN INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC
Young, Karen
Hargunani, Devesh
Poylin, Vitaliy
GASTROENTEROLOGY, 2022, 162 (03) : S81 - S81

← 1 2 3 4 5 →